93. Primary biliary cholangitis Clinical trials / Disease details


Clinical trials : 298 Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000040593
2020-12-012020-12-03Prevalence and prognostic risk of primary biliary cholangitis in Yunnan ProvincePrevalence and prognostic risk of primary biliary cholangitis in Yunnan Province primary biliary cholangitisGold Standard:PBC can be diagnosed by meeting 2 of the following 3 criteria :(1) serum biochemical indication of increased ALP;(2) When AMA is positive or AMA is negative, other PBC specific autoantibodies, such as SP100 and GP210 are positive;(3) Histological evidence suggested non-suppurative destructive cholangitis and inter-lobu;Index test:AMA in serum of suspected PBC cases was detected by traditional AMA-M2 test and BPO test, respectively.;The Second Affiliated Hospital of Kunming Medical UniversityNULLPendingMaleTarget condition:0;Difficult condition:0N/AChina
2ChiCTR2000032053
2020-05-012020-04-19Application value of ultrasonography combined with transient elastography for staging of hepatic fibrosis in patients with primary biliary cholangitis (PBC)Application value of ultrasonography combined with transient elastography for staging of hepatic fibrosis in patients with primary biliary cholangitis (PBC) primary biliary cholangitisGold Standard:Any two of the following items met:
1. increased biochemical indicators of cholestasis such as alkaline phosphatase;
2. positive serum AMA or AMA-M2;
3. hepatic histopathology.;Index test:high-frequency and low-frequency ultrasound?transient elastography (TE);
You'an Hospital, Capital Medical UniversityNULLPending1870BothTarget condition:100;Difficult condition:270N/AChina
3ChiCTR1900024836
2019-07-302019-07-30Exploration of non-invasive diagnostic model of liver fibrosis based on artificial intelligence in primary biliary cholangitis Clinical research protocolExploration of non-invasive diagnostic model of liver fibrosis based on artificial intelligence in primary biliary cholangitis Clinical research protocol Primary biliary cholangitisGold Standard:Liver biopsy pathology.;Index test:Non-invasive diagnostic model for liver fibrosis: including AST/PLT value index (APRI model), Forns model, S index, and based on this, a new non-invasive liver fibrosis diagnosis model is generated.;Beijing You'an Hospital, Capital Medical UniversityNULLRecruiting1880BothTarget condition:180;Difficult condition:180China